Efficacy of first-line treatments in the elderly and non-elderly patients with advanced epidermal growth factor receptor mutated, non-small cell lung cancer: a network meta-analysis

Efficacy of first-line treatments in the elderly and non-elderly patients with advanced epidermal growth factor receptor mutated, non-small cell lung cancer: a network meta-analysis

Objective: Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) are the current standard of care for advanced or metastatic non-small cell lung cancer (NSCLC) patients harboring EGFR activating mutations. However, the optimal strategy for elderly NSCLC patients is still under de...

Full description

Bibliographic Details
Main Authors: Li, J. (Author), Liu, C. (Author), Wang, L. (Author), Xie, T. (Author), Xing, P. (Author), Xu, Z. (Author), Zhu, Y. (Author), Zou, Z. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
EGFR-TKIs
Elderly
Network meta-analysis
Non-elderly
NSCLC
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items